Institute for Asthma and Allergy, PC

Chevy Chase, Maryland 20815

1 studies enrolling now · 12 studies all time

What they study most

Allergy, Peanut, Chronic Spontaneous Urticaria, Chronic Spontaneous Urticaria (CSU), Hereditary Angioedema, Hereditary Angioedema (HAE), Primary Immune Deficiency Diseases (PIDD)

Studies at this site

• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Study of PlasmaCap IG in Adults and Children With PIDD — Completed
• Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts — Completed
• Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks — Completed
• A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema — Completed
• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling
• A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema — Running, not enrolling
• A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. — Completed
• A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema — Completed
• Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema — Completed
• CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 — Completed
• Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks — Completed